Decreased glucocorticoid binding has been observed at a time after endotoxin (3 to 6 h) when impaired liver enzyme induction is known to occur. This study was undertaken to characterize the early time course of hypoglycemia and decreased liver phosphoenolpyruvate carboxykinase (PEPCK) activity in intact and adrenalectomized mice given endotoxin. In addition, altered steroid induction of hepatic PEPCK was examined in adrenalectomized mice given dexamethasone at intervals before and after a median lethal dose of endotoxin. Intact mice demonstrated a dramatic hyperglycemia at 1 h after endotoxin treatment, a response absent in adrenalectomized mice. Plasma glucose levels were significantly reduced from control values at 3 and 6 h posttreatment, with the most pronounced endotoxininduced hypoglycemia seen in adrenalectomized mice. Hepatic PEPCK activity in intact mice given endotoxin was decreased at 3 and 6 h after treatment, although no change from basal, noninduced levels was seen in poisoned adrenalectomized mice. The increased increment in hepatic PEPCK activity due to fasting of intact control mice was reproduced in adrenalectomized control mice by the administration of dexamethasone. Furthermore, the induction of hepatic PEPCK by dexamethasone was inhibited by 1 h after endotoxin treatment, with enzyme activity falling to basal, noninduced levels by 6 h posttreatment. At these same time intervals after endotoxin treatment, no evidence of histopathology in the liver or adrenal glands was seen. These results coincide with changes in steroid binding seen previously and indicate that endotoxin treatment produces significant alterations in glucocorticoid action at the subcellular or molecular level.
Decreased glucocorticoid binding has been observed at a time after endotoxin (3 to 6 h) when impaired liver enzyme induction is known to occur. This study was undertaken to characterize the early time course of hypoglycemia and decreased liver phosphoenolpyruvate carboxykinase (PEPCK) activity in intact and adrenalectomized mice given endotoxin. In addition, altered steroid induction of hepatic PEPCK was examined in adrenalectomized mice given dexamethasone at intervals before and after a median lethal dose of endotoxin. Intact mice demonstrated a dramatic hyperglycemia at 1 h after endotoxin treatment, a response absent in adrenalectomized mice. Plasma glucose levels were significantly reduced from control values at 3 and 6 h posttreatment, with the most pronounced endotoxininduced hypoglycemia seen in adrenalectomized mice. Hepatic PEPCK activity in intact mice given endotoxin was decreased at 3 and 6 h after treatment, although no change from basal, noninduced levels was seen in poisoned adrenalectomized mice. The increased increment in hepatic PEPCK activity due to fasting of intact control mice was reproduced in adrenalectomized control mice by the administration of dexamethasone. Furthermore, the induction of hepatic PEPCK by dexamethasone was inhibited by 1 h after endotoxin treatment, with enzyme activity falling to basal, noninduced levels by 6 h posttreatment. At these same time intervals after endotoxin treatment, no evidence of histopathology in the liver or adrenal glands was seen. These results coincide with changes in steroid binding seen previously and indicate that endotoxin treatment produces significant alterations in glucocorticoid action at the subcellular or molecular level.
Endotoxin administration to experimental animals induces a pronounced hypoglycemia (glucose levels of less than 70 mg/dl in mice [27] ) which arises from several discrete metabolic alterations (2, 12, (15) (16) (17) (18) 32) . Hypoglycemia also occurs in humans during acute bacterial sepsis and endotoxic shock (1, 20) . Impaired hepatic gluconeogenesis plays a major role in this response (19, 33) . A number of investigators have characterized changes in gluconeogenesis during experimental endotoxin treatment (11, 15, (23) (24) (25) . A key, rate-limiting enzyme of the gluconeogenic pathway, phosphoenolpyruvate carboxykinase (PEPCK) (14) , is primarily affected, and the studies of Berry et al. have shown that the glucocorticoid hormone induction of this enzyme is depressed after endotoxin treatment (3) .
To define endotoxin impairment of glucocorticoid-stimulated gluconeogenesis and to characterize early (within 6 h) events after endotoxin administration, we followed the time course of hypoglycemia and the reduction of liver PEPCK activity in intact and adrenalectomized mice given endotoxin. Furthermore, we examined the extent to which steroid induction of hepatic PEPCK activity could be altered by endotoxin treatment in adrenalectomized mice given dexamethasone at intervals before and after a median lethal dose of endotoxin. These data, combined with recent observations that within 3 to 6 h endotoxin treatment decreases the binding of
[3H]dexamethasone to specific receptors in liver cytosol preparations (26) , strongly suggest that perturbations in steroid action at the subcellular or molecular level are involved in the host response to endotoxin.
MATERIALS AND METHODS
Endotoxin. The endotoxin used in this study was a crude Boivin extract (6) of Escherichia coli serotype 0111:B4. Bacteria were cultured on brain heart infusion agar (Difco Laboratories, Detroit, Mich.) and were harvested during the late exponential phase of growth. The median lethal dose for this preparation was 4.7 mg/kg in intact mice and 2.3 jig/kg in adrenalectomized mice (26 15 ±l of liver cytosol. The protein content of the liver cytosol preparation was 25 to 28 mg/ml.
Light and electron microscopy. Pathological changes in adrenal glands and liver were examined by light microscopy after fixing tissues in 10% buffered Formalin, imbedding in paraffin, sectioning, and staining with hematoxylin and eosin. Ultrastructural examination was carried out with a JEOL 100 CX electron microscope (JEOL Inc., New Bedford, Mass.) on thin tissue sections fixed in 3% (wt/vol) glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.0). Organs from three sham-operated and three endotoxin-treated animals were removed at 1, 3, and 6 h posttreatment. One segment of liver and one adrenal gland from each animal were prepared for histological examination, and a second liver segment and the other adrenal gland were examined for ultrastructural changes.
Statistics. All results were analyzed for significant differences (P c 0.05) by Student's t test (21) .
RESULTS
Time course of endotoxin-induced hypoglycemia in intact and adrenalectomized mice. The time course of endotoxin-induced hypoglycemia was determined in both intact and adrenalectomized mice after intraperitoneal administration of 100 ,ug of E. coli endotoxin ( Fig. 1) . At 0 h, plasma glucose levels in intact control mice (140 + 8 mg/dl) were no different than those in adrenalectomized control mice (149 ± 9 mg/dl). Intact mice responded to endotoxin treatment with a dramatic hyperglycemia by 1 h after treatment (Fig. 1A) . The increase in plasma glucose from 145 to 225 mg/dl in intact mice was absent in adrenalectomized mice (Fig. 1B) . Glucose levels in endotoxin-treated mice were reduced significantly from control values (P . 0.05) in both intact and adrenalectomized mice at 3 and 6 h posttreatment. Glucose levels in control mice decreased from 145 mg/dl at 1 h to 86 mg/dl at 6 h, a decrease which reflects the normal circadian rhythm. Glucose levels in intact endotoxin-treated mice were 125 and 62 mg/ dl at 3 and 6 h, respectively. In adrenalectomized poisoned mice, blood glucose levels were 64 and 31 mg/dl at 3 and 6 h, respectively. Therefore, adrenalectomized mice exhibited lower blood glucose levels than intact animals after endotoxin treatment. At 6 h after treatment, progressively lower glucose levels were seen, as follows: intact control > intact treated = adrenalectomized control > adrenalectomized treated mice.
In contrast to the marked changes in plasma [27] ) after endotoxin treatment, significant changes were observed in hepatic PEPCK activity (Fig. 2) . PEPCK activity in intact mice was approximately 42 U at 0 h. Although PEPCK activity was unchanged at 1 h after endotoxin treatment in intact mice, a significant decrease (P < 0.05) was seen by 3 h after treatment, with an even greater decrease noted at 6 h. Enzyme activity decreased to 38 U, 61% of the control value, by 6 h.
There was no apparent change in hepatic PEPCK activity after endotoxin treatment in adrenalectomized mice. PEPCK activity was 32 U at 0 h. Enzyme activity ranged from 27 to 35 U in both control and poisoned mice at 1, 3, or 6 h after endotoxin treatment. This relatively low activity represents a basal, noninduced level expected in animals without intact adrenal glands. Thus, at 6 h after endotoxin treatment, PEPCK activity in intact mice was reduced to a level comparable to that seen in adrenalectomized control mice not given endotoxin. Exposure to endotoxin did not further decrease PEPCK activity in the adrenalectomized animals to below the basal level.
Glucocorticoid hormone induction of hepatic PEPCK in adrenalectomized mice. The time course studies characterizing changes in plasma glucose and hepatic PEPCK levels in adrenalectomized mice given endotoxin clearly suggested that the enzyme was glucocorticoid inducible. Therefore, the effects of overnight fasting, adrenalectomy, and reconstitution of adrenalectomized mice with dexamethasone treatment on plasma glucose and hepatic PEPCK activity were examined (Fig. 3) however, restored enzyme activity to levels normal for fasted intact mice. Therefore, the increase in plasma glucose and hepatic PEPCK activity seen in fasted intact mice was glucocorticoid related, since similar increases were seen in adrenalectomized mice given dexamethasone.
Influence of endotoxin treatment on dexamethasone induction of hepatic PEPCK. Since endotoxin has previously been reported to inhibit the cortisol-induced increase in mouse liver PEPCK (5), we examined the time course of dexamethasone induction of this enzyme in adrenalectomized mice given 100 ,ug of endotoxin. Animals were adrenalectomized and fasted overnight as in previous experiments. Endotoxin was given at 0800, and mice were killed and hepatic PEPCK activity was determined at 1, 3, and 6 h after treatment. All mice were given dexamethasone at 2 h before sacrifice, since PEPCK has a reported half-life of approximately 2 h (13) . With this protocol we were able to follow the time course of endotoxin inhibition of PEPCK enzyme induction by giving steroid before and at several intervals after endotoxin injection.
A steady decline in the ability of dexamethasone to induce hepatic PEPCK occurred with increasing time after exposure to endotoxin (Fig.  4) . Maximal activity (84 U) was measured in mice receiving steroid 2 h and 1 h before endotoxin. That level of enzyme activity was significantly reduced (P < 0.05), to 66 U, in mice receiving dexamethasone 1 h after endotoxin. An even greater decline, to 35 U, was noted in mice given steroid 4 h after endotoxin treatment. This low amount of enzyme activity corresponded to the noninduced basal level (Fig. 2  and 3) . The time course of decreased dexamethasone induction of liver enzyme coincided with decreased dexamethasone binding by liver cytosolic receptors, reported previously (27) .
Histological examination of liver and adrenal tissue in poisoned mice. Liver and adrenal tissues were examined histologically to determine whether pathological damage was associated with the biochemical changes seen. Liver and adrenal glands were obtained from intact mice at 1, 3, and 6 h after endotoxin treatment. No major changes were noted at the light microscopic level in either the liver or the adrenals from poisoned mice. There was a mild leukocyte infiltration into both tissues, but no evidence of overt tissue or vascular damage was seen. Ultrastructural examination of these tissues also failed to reveal significant pathological changes at these time intervals after endotoxin treatment. There was no evidence of plasma membrane abnormality nor were any significant mitochondrial or nuclear changes noted 6 h after treatment. Thus, there was no evidence of pathological tissue damage early after endotoxin treatment when significant impairment of dexamethasone induction of hepatic PEPCK was seen.
DISCUSSION
Alterations in carbohydrate metabolism leading to severe hypoglycemia are a fundamental host response to shock (11, 15, 18) . The subcellular or molecular mechanisms involved in the induction of hypoglycemia by endotoxin have been studied only recently (2, 3, 24) and are incompletely understood. The term hypoglycemia does not simply refer to lowered blood glucose levels but, rather, to an abnormally diminished content of glucose in the blood which may result in chills, hypothermia, and headache, ultimately leading to convulsions and coma. In the mouse model used in this study, hypoglycemia is defined as a blood glucose value of less than 70 mg/dl, a value two standard deviations below the normal fasting value of 92 mg/dl (27) .
We believe that hypoglycemia after endotoxin administration is a complex problem arising from several causative factors. Among the contributory causes may be impaired action of glu-coneogenic hormones, including glucocorticoids, glucagon, and epinephrine, altered sympathetic innervation of the liver, and increased peripheral utilization of glucose beyond the ability of the liver to maintain normoglycemia.
Glucocorticoids play an important role in the action of glucagon (and perhaps epinephrine) and, thus, contribute significantly to hepatic carbohydrate metabolism. Glucocorticoid regulation of plasma glucose levels under basal and stressed conditions is exemplified by the following observations. (i) Adrenalectomized animals may display near-normal plasma glucose concentrations in basal or resting states, but in a state of stress, such as diabetes mellitus or starvation, their ability to produce glucose is impaired. (ii) According to Exton (9) , adrenalectomized animals and patients suffering from Addison's disease are prone to die in hypoglycemia during modest starvation, an effect attributed to the failure of gluconeogenesis. Adrenalectomy abolishes the increases in gluconeogenesis precipitated by starvation, diabetes, and glucagon (9) . (iii) The regulation of the synthesis of PEPCK, the key enzyme in hepatic glucose production (excluding glycogenolysis), appears to be a major mechanism by which glucocorticoids regulate hepatic gluconeogenesis (14) . Our working hypothesis is that an early effect of endotoxin or its mediator(s) is to impair hepatic glucocorticoid responsiveness, a change which contributes significantly to the onset of hypoglycemia. The experiments described here were undertaken to characterize the early effect of endotoxin administration on hepatic glucocorticoid action and to relate this to plasma glucose levels.
The endotoxin preparation used was a crude Boivin extract of E. coli since during gramnegative septicemia relatively impure cell wall complexes are presented to the host. This is not a major point, however, since the metabolic changes seen in shock may be reproduced with either crude cell wall preparations or highly purified lipopolysaccharide fractions (24) .
The results presented in Fig. 1 and 2 substantiate the profound influence of the adrenal glands on the host response to endotoxin. The initial hyperglycemia seen after endotoxin treatment of intact mice was absent in adrenalectomized mice. Since endotoxin-induced hyperglycemia was not restored in adrenalectomized mice given glucocorticoids (the glucose level was 138 mg/dl 1 h after endotoxin treatment compared with 225 mg/dl in intact mice 1 h after endotoxin treatment), the early hyperglycemic response in intact animals is most likely mediated by adrenal medullary catecholamines. At later times after endotoxin treatment, there was a marked reduction in plasma glucose levels in both intact and adrenalectomized mice.
Variations in blood glucose levels in control mice sampled at various times of the day are due to the normal circadian rhythm, observed even in fasting animals (22, 27) . The pronounced depression of blood glucose (to as low as 4 mg/dl in some animals; group mean = 31 mg/dl) which occurred in endotoxin-treated adrenalectomized mice at 6 h was significantly greater than that seen in intact animals (60 mg/dl). We have previously reported (26) that adrenalectomized C3HeB/FeJ mice are approximately 2,000-fold more sensitive than intact control mice to the lethal effects of endotoxin (median lethal dose for intact mice = 5.5 mg/kg; median lethal dose for adrenalectomized mice = 2.5 ,ug/kg [26] ). Thus, the severe hypoglycemia recorded in adrenalectomized animals correlates with increased sensitivity to endotoxin. Comparable plasma glucose levels in intact mice 6 h after endotoxin administration and in control adrenalectomized mice 6 h after sham treatment suggest that the intact animals were functionally adrenalectized by endotoxin treatment.
The inhibition of hepatic PEPCK seen in intact mice given endotoxin (Fig. 2) is consistent with previous results (5, 30) and indicates that the enzyme is a sensitive marker of endotoxin poisoning since a significant inhibition was noted as early as 3 h after treatment. By 6 h after endotoxin administration, PEPCK activity was reduced to approximately 60% of the control value, a level of catalytic activity insufficient to drive the gluconeogenic pathway required in animals subjected to stress (9) . Therefore, endotoxin poisoning inhibits the host compensatory response that is usually reflected by new protein synthesis of key enzymes in intermediary metabolism.
The absence of an effect of endotoxin on hepatic PEPCK in adrenalectomized mice (Fig.  2) further supports the contention that endotoxin affects the glucocorticoid inducibility of this enzyme (13, 29) but does not act directly on the enzyme. Berry and associates have partially characterized the inhibition of steroid induction of several liver enzymes, including tryptophan oxygenase and PEPCK (5, 30, 31) . The results presented in Fig. 2 and 4 extend these studies by establishing a time course for the inhibition of steroid induction of hepatic PEPCK. Our findings are consistent with previous observations on the response of tryptophan oxygenase to endotoxin (4). For enzymes with short half-lives (2 to 3 h), a decline in total catalytic activity can reflect a reduction in the synthetic rate over the time intervals studied in our experiments. A reduction in enzyme activity (Fig. 2) as well as an inhibition of PEPCK induction (Fig. 4) was VOL. 39, 1983 on September 29, 2017 by guest http://iai.asm.org/ Downloaded from observed as early as 3 h posttreatment. Since in the induction experiment (Fig. 4) (26) since we measured high-affinity, glucocorticoid-specific binding and not cellular uptake of steroid. The biological significance of the blocking of activated hormone-receptor complex binding to DNA is complicated by the requirement for high concentrations of active endotoxin and by the observation that biologically detoxified endotoxin inhibits activated hormone-receptor complex binding even more efficiently than does toxic endotoxin. If these transcriptional blocks do occur in vivo, then our data suggest that they are later events since PEPCK activity (basal level) is not further reduced in adrenalectomized mice at 6 h.
In summary, we found that endotoxin treatment resulted in lowered plasma glucose levels, reduced hepatic PEPCK activity, and diminished hepatic glucocorticoid binding in the same time-and dose-dependent fashion. Furthermore, endotoxin prevented glucocorticoid induction of PEPCK at a time after treatment coincident with the decrease in steroid binding and the development of hypoglycemia. Endotoxin treatment resulted in early biochemical changes that underlie the metabolic alterations characteristic of lethal endotoxic shock and subsequent histological damage to tissues. We believe that an understanding of the alteration in glucocorticoid action in the endotoxin-poisoned liver is a first step in clarifying one aspect of this complex problem of defining primary mechanisms underlying endotoxic shock.
